메뉴 건너뛰기




Volumn 89, Issue 11 SUPPL., 2000, Pages 2465-2467

Considerations in developing successful, population-based molecular screening and prevention of lung cancer

Author keywords

Heterogeneous nuclear ribonucleoprotein A2 B1, lung cancer, molecular screening, mortality rate

Indexed keywords

RIBONUCLEOPROTEIN; TUMOR MARKER;

EID: 0034553833     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001201)89:11+<2465::aid-cncr24>3.0.co;2-6     Document Type: Conference Paper
Times cited : (13)

References (20)
  • 2
    • 0002878212 scopus 로고    scopus 로고
    • Biomarkers as intermediate endpoints in chemoprevention trials
    • Martinet Y, Matinet N, Vignaud JM, Hirsch F, Mulshine JL, editors. Biological basis of lung cancer prevention. Basel: Birkhauser
    • (1998) , pp. 305-312
    • Papadimitrakopoulou, V.A.1    Hong, W.K.2
  • 8
    • 4243213858 scopus 로고    scopus 로고
    • Cancer prevention and early detection in the year 2013
    • Brown HG, Seffrin JR, editors. Horizon 2013. Atlanta: American Cancer Society
    • (1996) , pp. 223-237
    • Smart, C.1    Mulshine, J.L.2
  • 11
    • 0001832393 scopus 로고    scopus 로고
    • Regional delivery of retinoids: A new approach to early lung cancer intervention
    • Martinet Y, Vignaud JM, Martinet N, Hirsch F, Mulshine JL, editors. Clinical and biological basis of lung cancer prevention. Basel: Birkhauser
    • (1998) , pp. 273-284
    • Mulshine, J.L.1    De Luca, L.M.2    Dedrick, R.L.3
  • 15
    • 0029796637 scopus 로고    scopus 로고
    • Retinoids in cancer chemoprevention
    • (1996) FASEB J , vol.10 , pp. 1031-1039
    • Lotan, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.